Wenqing Yao

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

Bin-Bing Zhou, Michael Peyton, Biao He et al. · Cancer Cell · 2006 · 375 citations · Full text

Medicine, Molecular Biology, Oncology +11

The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

Julio Rosenstock, Salomon Banarer, Vivian Fonseca et al. · Diabetes Care · 2010 · 314 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Aggrecan Protects Cartilage Collagen from Proteolytic Cleavage

Michael A. Pratta, Wenqing Yao, Carl P. Decicco et al. · Journal of Biological Chemistry · 2003 · 294 citations · Full text

Dentistry, Pathobiology, Cartilage Repair +15

A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3

Xiangdong Liu, Qian Wang, Gengjie Yang et al. · Clinical Cancer Research · 2011 · 274 citations

Medicine, Oncology, Pharmacology +16

Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells

Phillip C.C. Liu, Xiangdong Liu, Yanlong Li et al. · Cancer Biology & Therapy · 2006 · 186 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17